When was MediSapiens founded?

MediSapiens was founded in 2009 and raised its 1st funding round 1 year after it was founded.

Where is MediSapiens located?

MediSapiens is headquartered in Helsinki, Finland.

How many employees does MediSapiens have?

As of May 31, 2026, the latest employee count at MediSapiens is 2.

Is MediSapiens a funded company?

MediSapiens is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Jun 01, 2010.

When was the latest funding round of MediSapiens?

MediSapiens' latest funding was a $***** Seed round on Jun 01, 2010, with participation from 4 investors. Its primary sector is Life Sciences Platforms and Tools. Globally, the Life Sciences Platforms and Tools sector has seen $1.16B in funding in 2026 to date.

Where does MediSapiens rank among its competitors?

MediSapiens ranks 1248th amongst 2560 active competitors, of which 582 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was Antheia, which secured $24M in Jan, 2026.

Who are the top competitors of MediSapiens?

MediSapiens' top competitors include Benchling, Helix and Synthego. Among them, Antheia secured the most recent funding round in January, 2026.

MediSapiens - 2026 Company Profile, Team, Funding & Competitors

MediSapiens is a seed company based in Helsinki (Finland), founded in 2009. It operates as a Clinical insights through Bioinformatics. MediSapiens has raised $1M in funding from Eqvitec Partners and Finnvera. The company has 2560 active competitors, including 582 funded and 370 that have exited. Its top competitors include companies like Benchling, Helix and Synthego.

Company Details

MediSapiens is a bioinformatics company, based in Helsinki, Finland and Cambridge, Massachusetts, with a background in pharmaceutical research and translational genomics. The company provides pharmaceutical and biomedical research organizations with tools that help them design more effective personalized drugs against life-threatening diseases. MediSapiens creates powerful and intuitive software platforms to manage, integrate, and visualize complex multi-dimensional datasets, such as genomic sequencing data. The company's goal is to drive medicine forward by developing tools that provide scientists with a way to quickly analyze and visualize vast amounts of data and turn it into knowledge that fuels innovation.

Website: medisapiens.com
Social

Key Metrics

Founded Year

2009

Location

Helsinki, Finland

Stage

Seed

Total Funding

$1M in 1 round

Latest Funding Round

Seed, Jun 01, 2010, $*****

Investors

Eqvitec Partners & 5 more

Ranked

1248^th among 2560 active competitors

Employee Count

2 as on May 31, 2026

Similar Companies

Benchling & 3438 more

View MediSapiens' full profile

MediSapiens has raised a total funding of $1M over 1 round. Its latest funding round was a Seed round on Jun 01, 2010 for $*****. 4 investors participated in its latest round. MediSapiens has 6 institutional investors.

Here is the list of recent funding rounds of MediSapiens:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 01, 2010	1878725	Seed	6752923	8559915	1739590	4194960

Access funding benchmarks and valuations. Sign up today!

View details of MediSapiens's funding rounds and investors

MediSapiens' employee count trend

MediSapiens has 2 employees as of May 26. Here is MediSapiens's employee count trend over the years:

Uncover MediSapiens' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of MediSapiens include Benchling, Helix and Synthego. Here is the list of Top 10 competitors of MediSapiens, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Benchling 2012, San Francisco (United States), Series F	Provider of a cloud-based bioinformatics platform for biotech research	$412M	Altimeter Capital, Menlo Ventures & 28 others	73/100
2nd	Helix 2015, San Francisco (United States), Series E	Provider of a genomic database for clinical research	$435M	DFJ Growth, Kleiner Perkins & 12 others	71/100
3rd	Synthego 2012, Redwood City (United States), Acquired	Developer of CRISPR-engineered cell and gene therapies	$460M	8VC, Perceptive Advisors & 30 others	71/100
4th	DNAnexus 2009, Mountain View (United States), Series H	Provider of cloud-based genome informatics & data management platform	$473M	Google Ventures, TPG & 21 others	70/100
5th	Insitro 2018, San Francisco (United States), Series C	Developer of machine learning platform for drug discovery and development	$643M	Andreessen Horowitz, Foresite Capital & 18 others	70/100
6th	Antheia 2013, Palo Alto (United States), Series C	Genetically engineered yeast cells to produce medicinal products	$176M	Viking Global Investors, ATHOS KG & 15 others	67/100
7th	Transcenta 2019, Suzhou (China), Public	Developer of antibody-based therapeutics	$205M	Lilly Asia Ventures, Temasek & 11 others	66/100
8th	Immunai Technologies 2018, United States, Series B	Developer of next-generation of immunomodulatory therapeutics	$295M	Viola Group, TLV Partners & 14 others	66/100
9th	Judges Scientific 2002, London (United Kingdom), Public	Acquisition and development of scientific instrument businesses	-	Origin Capital, Lloyds Banking Group	65/100
10th	Asimov 2017, Boston (United States), Series B	Provider of integrated suite for advanced genetic design and manufacturing	$234M	Andreessen Horowitz, Horizons Ventures & 11 others	65/100
1248th	MediSapiens 2009, Helsinki (Finland), Seed	Clinical insights through Bioinformatics	$1M	Finnvera, Eqvitec Partners & 4 others	27/100